Key Developments: Smith & Nephew PLC (SNN.N)
29 Aug 2014
Latest Key Developments (Source: Significant Developments)
Smith & Nephew Plc:Declares interim dividend of 2014 of $ 0.11 per ordinary share was declared by Board on July 31.Dividend is payable on Nov. 11 to shareholders whose names appear on register at close of business on Oct. 24. Full Article
SENTENCE REMOVED - "Says that for FY 2014 it remains on track to meet guidance of mid teens revenue growth"....IN THE BODY (SEGMENTAL OUTLOOK).Smith & Nephew Plc:Says that for FY 2014 it remain confident in overall Group outlook. Full Article
Smith & Nephew PLC:Appointment of KPMG LLP (KPMG) as its auditor for year ending Dec .31, 2015, subject to approval by shareholders at 2015 AGM. Full Article
Smith & Nephew PLC enters commercial agreement to bring robotic navigation to JOURNEY UNI Knee procedure
Smith & Nephew PLC:Says new commercial agreement with Blue Belt Technologies.Under this agreement, surgeons using Navio system will be able to implant Smith & Nephew's JOURNEY UNI partial knee. Full Article
Smith & Nephew PLC:Completes acquisition of ArthroCare Corporation.Purchase price was $48.25 per share paid in cash, translating into an enterprise value of about $1.5 bln. Full Article
Smith & Nephew PLC:As announced on Feb. 06, 2014, final dividend of $0.17 per share per ordinary share in respect of the year ended Dec. 31, 2013.Payable on May 07.Record date is April 22. Full Article
Smith & Nephew plc:Launches JOURNEY II Cruciate Retaining (CR) knee replacement at American Academy of Orthopaedic Surgeons (AAOS) meeting in New Orleans.New implant extends JOURNEY II Total Knee System to procedures that preserve posterior cruciate ligament (PCL), which accounts for about half of all knee replacement procedures. Full Article
Smith & Nephew and OrthoSensor to co-market VERASENSE Sensor Assisted Surgery with JOURNEY II and LEGION Total Knee Replacements
Smith & Nephew PlC and OrthoSensor:Agreement that will enable surgeons to benefit from OrthoSensor's VERASENSE Sensor Assisted Surgery Technology for soft tissue balancing when implanting Smith & Nephew's JOURNEY II and LEGION Total Knee Systems.VERASENSE utilizes advanced sensor technologies to enable evidence-based surgical decisions regarding component position, limb alignment and soft tissue balance to optimize outcomes in total knee replacement. Full Article
Smith & Nephew PLC:Recommends a final dividend of $0.17 per share ($0.85 per ADS).This, together with interim dividend of $0.104 per share ($0.52 per ADS), will give a full year distribution of $0.274 per share ($0.137 per ADS), up five pct year-on-year. Full Article
WASHINGTON, Aug 29 - A U.S. judge sentenced the former chief executive of surgical device maker ArthroCare to 20 years in prison and its finance chief to 10 years after a jury convicted the pair of orchestrating a $750 million securities fraud scheme, the U.S. Department of Justice said on Friday.
- 3 FTSE 100 Stocks Up On M&A Talk: Vodafone Group plc, Smith & Nephew plc And AstraZeneca plc
- Is AstraZeneca plc’s Latest Director Deal A Game-Changer?
- Is It Time To Cash In On Takeover Target Smith & Nephew plc?
- Transcript: Should You Buy Shares In TSB?
- Could It Be Time For A Takeover Of Smith & Nephew plc?
- Smith & Nephew plc: Shining Bright In A Greying World